Drugs / Novo regular insulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00487162 Comparator | Jun 2007 → Jan 2009 | hyperglycemia | University of Medicine and Dentistry of New Jersey | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novo regular insulin | “Novo regular insulin administered when glucose level exceeded 200 mg/dl and titrated to maintain level between 180-200 mg/dl” NCT00487162 ↗ |
| Route | Intravenous | “intravenous insulin titrated every 30 minutes to serum glycemic level of 80-100mg/dl” NCT00487162 ↗ |